Epidermal Growth Factor Receptor, p53 Mutation, and Pathological Response Predict Survival in Patients with Locally Advanced Esophageal Cancer Treated with Preoperative Chemoradiotherapy
Michael K. Gibson, Susan C. Abraham, Tsung Teh Wu, Barbara Burtness, Richard F. Heitmiller, Elisabeth Heath, Arlene Forastiere
Dive into the research topics of 'Epidermal Growth Factor Receptor, p53 Mutation, and Pathological Response Predict Survival in Patients with Locally Advanced Esophageal Cancer Treated with Preoperative Chemoradiotherapy'. Together they form a unique fingerprint.